Zimmer Biomet Holdings Inc. (ZBH) News
Filter ZBH News Items
ZBH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ZBH News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ZBH News From Around the Web
Below are the latest news stories about ZIMMER BIOMET HOLDINGS INC that investors may wish to consider to help them evaluate ZBH as an investment opportunity.
Zimmer Biomet price target raised to $113 from $110 at Evercore ISIEvercore ISI raised the firm’s price target on Zimmer Biomet (ZBH) to $113 from $110 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, the analyst argues that FY25 guides from the life science tools group are likely to be conservative on China and Pharma, while in MedTech the firm contends that “healthy” utilization trends and a margin expansion thesis support the group. Published first on TheFly – the ultimate source for |
Zimmer Biomet: The Valuation Discount Is Not JustifiedZimmer Biomet's business turnaround has not been recognized by the market |
ZBH Stock to Benefit From Global Expansion Despite Macro IssuesZimmer Biomet is witnessing strong market share gains within reconstructive Knees and Hips in key geographies despite macroeconomic challenges. |
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceZimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 8:15 a.m. PT (11:15 a.m. ET). |
Zimmer Biomet price target raised to $118 from $117 at TruistTruist raised the firm’s price target on Zimmer Biomet (ZBH) to $118 from $117 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in Medical Technology. The firm sees the sector as “one of the better/safer houses” in healthcare given its lower “front-line” exposure to healthcare policy rhetoric that is tied to the administration change as well as its position as an “innovation segment” with sustainable above-average revenue and EPS growth, strong balance she |
NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ...Despite a challenging quarter, NeuroOne Medical Technologies Corp (NMTC) anticipates robust revenue growth in 2025, driven by new FDA approvals and strategic alliances. |
Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years agoIdeally, your overall portfolio should beat the market average. But even the best stock picker will only win with some... |
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2024. The cash dividend of $0.24 per share is payable on or about January 31, 2025 to stockholders of record as of the close of business on December 30, 2024. |
Q4 2024 Neuroone Medical Technologies Corp Earnings CallQ4 2024 Neuroone Medical Technologies Corp Earnings Call |
Tesla upgraded, MongoDB initiated: Wall Street's top analyst callsTesla upgraded, MongoDB initiated: Wall Street's top analyst calls |